ArticleOncology and therapy2021

Cost-Effectiveness of Pembrolizumab for the Adjuvant Treatment of Melanoma Patients with Lymph Node Involvement Who Have Undergone Complete Resection in Argentina.

Victoria Wurcel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.